Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combination
AT-01B-010
Phase 1 small_molecule active
Quick answer
Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combination for Healthy Volunteer Study is a Phase 1 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Healthy Volunteer Study
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active